المؤلفون: Lara Goscé (11485929), Gerard J. Abou Jaoude (11485932), David J. Kedziora (10573094), Clemens Benedikt (230638), Azfar Hussain (11485935), Sarah Jarvis (4925683), Alena Skrahina (5504123), Dzmitry Klimuk (11485938), Henadz Hurevich (11485941), Feng Zhao (90241), Nicole Fraser-Hurt (2636833), Nejma Cheikh (4487677), Marelize Gorgens (316352), David J. Wilson (11485944), Romesh Abeysuriya (8824172), Rowan Martin-Hughes (4431142), Sherrie L. Kelly (3753985), Anna Roberts (8969096), Robyn M. Stuart (3754000), Tom Palmer (159714), Jasmina Panovska-Griffiths (637509), Cliff C. Kerr (11185804), David P. Wilson (9160266), Hassan Haghparast-Bidgoli (3141792), Jolene Skordis (6417764), Ibrahim Abubakar (217017)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, using program objectives, similar modelling tools, relatively high burden, related deaths occur, focused care models, effective priority setting, 50 %, respectively, spending across existing, resistant tb infections, support analytical capacity, new interventions could, differentiated general populations, optima tb framework, middle income country, improve health impact, programmatic cost functions, optima tb tool, optima tb, tb spending, income countries, health resources

Relation: https://figshare.com/articles/journal_contribution/Transmission_model_and_epidemiological_rationale_/16687851

الاتاحة: https://doi.org/10.1371/journal.pcbi.1009255.s001

المؤلفون: Lara Goscé (11485929), Gerard J. Abou Jaoude (11485932), David J. Kedziora (10573094), Clemens Benedikt (230638), Azfar Hussain (11485935), Sarah Jarvis (4925683), Alena Skrahina (5504123), Dzmitry Klimuk (11485938), Henadz Hurevich (11485941), Feng Zhao (90241), Nicole Fraser-Hurt (2636833), Nejma Cheikh (4487677), Marelize Gorgens (316352), David J. Wilson (11485944), Romesh Abeysuriya (8824172), Rowan Martin-Hughes (4431142), Sherrie L. Kelly (3753985), Anna Roberts (8969096), Robyn M. Stuart (3754000), Tom Palmer (159714), Jasmina Panovska-Griffiths (637509), Cliff C. Kerr (11185804), David P. Wilson (9160266), Hassan Haghparast-Bidgoli (3141792), Jolene Skordis (6417764), Ibrahim Abubakar (217017)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, using program objectives, similar modelling tools, relatively high burden, related deaths occur, focused care models, effective priority setting, 50 %, respectively, spending across existing, resistant tb infections, support analytical capacity, new interventions could, differentiated general populations, optima tb framework, middle income country, improve health impact, programmatic cost functions, optima tb tool, optima tb, tb spending, income countries, health resources

Relation: https://figshare.com/articles/journal_contribution/Intervention_cost_and_effect_inputs_including_/16687854

الاتاحة: https://doi.org/10.1371/journal.pcbi.1009255.s002

المؤلفون: Lara Goscé (11485929), Gerard J. Abou Jaoude (11485932), David J. Kedziora (10573094), Clemens Benedikt (230638), Azfar Hussain (11485935), Sarah Jarvis (4925683), Alena Skrahina (5504123), Dzmitry Klimuk (11485938), Henadz Hurevich (11485941), Feng Zhao (90241), Nicole Fraser-Hurt (2636833), Nejma Cheikh (4487677), Marelize Gorgens (316352), David J. Wilson (11485944), Romesh Abeysuriya (8824172), Rowan Martin-Hughes (4431142), Sherrie L. Kelly (3753985), Anna Roberts (8969096), Robyn M. Stuart (3754000), Tom Palmer (159714), Jasmina Panovska-Griffiths (637509), Cliff C. Kerr (11185804), David P. Wilson (9160266), Hassan Haghparast-Bidgoli (3141792), Jolene Skordis (6417764), Ibrahim Abubakar (217017)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, using program objectives, similar modelling tools, relatively high burden, related deaths occur, focused care models, effective priority setting, 50 %, respectively, spending across existing, resistant tb infections, support analytical capacity, new interventions could, differentiated general populations, optima tb framework, middle income country, improve health impact, programmatic cost functions, optima tb tool, optima tb, tb spending, income countries, health resources

Relation: https://figshare.com/articles/journal_contribution/Summary_of_modelling_process_in_relation_to_TB_MAC_country_level_modelling_guidance_/16687857

الاتاحة: https://doi.org/10.1371/journal.pcbi.1009255.s003

المؤلفون: Lara Goscé (11485929), Gerard J. Abou Jaoude (11485932), David J. Kedziora (10573094), Clemens Benedikt (230638), Azfar Hussain (11485935), Sarah Jarvis (4925683), Alena Skrahina (5504123), Dzmitry Klimuk (11485938), Henadz Hurevich (11485941), Feng Zhao (90241), Nicole Fraser-Hurt (2636833), Nejma Cheikh (4487677), Marelize Gorgens (316352), David J. Wilson (11485944), Romesh Abeysuriya (8824172), Rowan Martin-Hughes (4431142), Sherrie L. Kelly (3753985), Anna Roberts (8969096), Robyn M. Stuart (3754000), Tom Palmer (159714), Jasmina Panovska-Griffiths (637509), Cliff C. Kerr (11185804), David P. Wilson (9160266), Hassan Haghparast-Bidgoli (3141792), Jolene Skordis (6417764), Ibrahim Abubakar (217017)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, using program objectives, similar modelling tools, relatively high burden, related deaths occur, focused care models, effective priority setting, 50 %, respectively, spending across existing, resistant tb infections, support analytical capacity, new interventions could, differentiated general populations, optima tb framework, middle income country, improve health impact, programmatic cost functions, optima tb tool, optima tb, tb spending, income countries, health resources

Relation: https://figshare.com/articles/figure/Schematic_of_an_Optima_TB_analysis_source_OCDS_/16687860

الاتاحة: https://doi.org/10.1371/journal.pcbi.1009255.g001

المؤلفون: Lara Goscé (11485929), Gerard J. Abou Jaoude (11485932), David J. Kedziora (10573094), Clemens Benedikt (230638), Azfar Hussain (11485935), Sarah Jarvis (4925683), Alena Skrahina (5504123), Dzmitry Klimuk (11485938), Henadz Hurevich (11485941), Feng Zhao (90241), Nicole Fraser-Hurt (2636833), Nejma Cheikh (4487677), Marelize Gorgens (316352), David J. Wilson (11485944), Romesh Abeysuriya (8824172), Rowan Martin-Hughes (4431142), Sherrie L. Kelly (3753985), Anna Roberts (8969096), Robyn M. Stuart (3754000), Tom Palmer (159714), Jasmina Panovska-Griffiths (637509), Cliff C. Kerr (11185804), David P. Wilson (9160266), Hassan Haghparast-Bidgoli (3141792), Jolene Skordis (6417764), Ibrahim Abubakar (217017)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, using program objectives, similar modelling tools, relatively high burden, related deaths occur, focused care models, effective priority setting, 50 %, respectively, spending across existing, resistant tb infections, support analytical capacity, new interventions could, differentiated general populations, optima tb framework, middle income country, improve health impact, programmatic cost functions, optima tb tool, optima tb, tb spending, income countries, health resources

Relation: https://figshare.com/articles/figure/Calibration_output_graphs_/16687866

الاتاحة: https://doi.org/10.1371/journal.pcbi.1009255.g003

المؤلفون: Lara Goscé (11485929), Gerard J. Abou Jaoude (11485932), David J. Kedziora (10573094), Clemens Benedikt (230638), Azfar Hussain (11485935), Sarah Jarvis (4925683), Alena Skrahina (5504123), Dzmitry Klimuk (11485938), Henadz Hurevich (11485941), Feng Zhao (90241), Nicole Fraser-Hurt (2636833), Nejma Cheikh (4487677), Marelize Gorgens (316352), David J. Wilson (11485944), Romesh Abeysuriya (8824172), Rowan Martin-Hughes (4431142), Sherrie L. Kelly (3753985), Anna Roberts (8969096), Robyn M. Stuart (3754000), Tom Palmer (159714), Jasmina Panovska-Griffiths (637509), Cliff C. Kerr (11185804), David P. Wilson (9160266), Hassan Haghparast-Bidgoli (3141792), Jolene Skordis (6417764), Ibrahim Abubakar (217017)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, using program objectives, similar modelling tools, relatively high burden, related deaths occur, focused care models, effective priority setting, 50 %, respectively, spending across existing, resistant tb infections, support analytical capacity, new interventions could, differentiated general populations, optima tb framework, middle income country, improve health impact, programmatic cost functions, optima tb tool, optima tb, tb spending, income countries, health resources

Relation: https://figshare.com/articles/figure/Structure_of_the_epidemiological_model_at_the_core_of_Optima_TB_/16687863

الاتاحة: https://doi.org/10.1371/journal.pcbi.1009255.g002

المؤلفون: Lara Goscé (11485929), Gerard J. Abou Jaoude (11485932), David J. Kedziora (10573094), Clemens Benedikt (230638), Azfar Hussain (11485935), Sarah Jarvis (4925683), Alena Skrahina (5504123), Dzmitry Klimuk (11485938), Henadz Hurevich (11485941), Feng Zhao (90241), Nicole Fraser-Hurt (2636833), Nejma Cheikh (4487677), Marelize Gorgens (316352), David J. Wilson (11485944), Romesh Abeysuriya (8824172), Rowan Martin-Hughes (4431142), Sherrie L. Kelly (3753985), Anna Roberts (8969096), Robyn M. Stuart (3754000), Tom Palmer (159714), Jasmina Panovska-Griffiths (637509), Cliff C. Kerr (11185804), David P. Wilson (9160266), Hassan Haghparast-Bidgoli (3141792), Jolene Skordis (6417764), Ibrahim Abubakar (217017)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, using program objectives, similar modelling tools, relatively high burden, related deaths occur, focused care models, effective priority setting, 50 %, respectively, spending across existing, resistant tb infections, support analytical capacity, new interventions could, differentiated general populations, optima tb framework, middle income country, improve health impact, programmatic cost functions, optima tb tool, optima tb, tb spending, income countries, health resources

Relation: https://figshare.com/articles/figure/National_TB_spending_in_Belarus_in_2015_compared_with_optimised_annual_budget_to_minimise_active_TB_prevalence_and_incidence_and_TB-related_mortality_by_2035_/16687869

الاتاحة: https://doi.org/10.1371/journal.pcbi.1009255.g004

المؤلفون: Lara Goscé (11485929), Gerard J. Abou Jaoude (11485932), David J. Kedziora (10573094), Clemens Benedikt (230638), Azfar Hussain (11485935), Sarah Jarvis (4925683), Alena Skrahina (5504123), Dzmitry Klimuk (11485938), Henadz Hurevich (11485941), Feng Zhao (90241), Nicole Fraser-Hurt (2636833), Nejma Cheikh (4487677), Marelize Gorgens (316352), David J. Wilson (11485944), Romesh Abeysuriya (8824172), Rowan Martin-Hughes (4431142), Sherrie L. Kelly (3753985), Anna Roberts (8969096), Robyn M. Stuart (3754000), Tom Palmer (159714), Jasmina Panovska-Griffiths (637509), Cliff C. Kerr (11185804), David P. Wilson (9160266), Hassan Haghparast-Bidgoli (3141792), Jolene Skordis (6417764), Ibrahim Abubakar (217017)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, using program objectives, similar modelling tools, relatively high burden, related deaths occur, focused care models, effective priority setting, 50 %, respectively, spending across existing, resistant tb infections, support analytical capacity, new interventions could, differentiated general populations, optima tb framework, middle income country, improve health impact, programmatic cost functions, optima tb tool, optima tb, tb spending, income countries, health resources

Relation: https://figshare.com/articles/figure/Projected_impact_of_2015_and_optimised_allocations_of_national_TB_spending_on_key_TB_indicators_among_HIV-negative_adults_and_people_living_with_HIV_from_2015_to_2035_/16687872

الاتاحة: https://doi.org/10.1371/journal.pcbi.1009255.g005

المؤلفون: Lara Goscé (11485929), Gerard J. Abou Jaoude (11485932), David J. Kedziora (10573094), Clemens Benedikt (230638), Azfar Hussain (11485935), Sarah Jarvis (4925683), Alena Skrahina (5504123), Dzmitry Klimuk (11485938), Henadz Hurevich (11485941), Feng Zhao (90241), Nicole Fraser-Hurt (2636833), Nejma Cheikh (4487677), Marelize Gorgens (316352), David J. Wilson (11485944), Romesh Abeysuriya (8824172), Rowan Martin-Hughes (4431142), Sherrie L. Kelly (3753985), Anna Roberts (8969096), Robyn M. Stuart (3754000), Tom Palmer (159714), Jasmina Panovska-Griffiths (637509), Cliff C. Kerr (11185804), David P. Wilson (9160266), Hassan Haghparast-Bidgoli (3141792), Jolene Skordis (6417764), Ibrahim Abubakar (217017)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, using program objectives, similar modelling tools, relatively high burden, related deaths occur, focused care models, effective priority setting, 50 %, respectively, spending across existing, resistant tb infections, support analytical capacity, new interventions could, differentiated general populations, optima tb framework, middle income country, improve health impact, programmatic cost functions, optima tb tool, optima tb, tb spending, income countries, health resources

Relation: https://figshare.com/articles/dataset/Key_population_statistics_/16687878

الاتاحة: https://doi.org/10.1371/journal.pcbi.1009255.t001

المؤلفون: Lara Goscé (11485929), Gerard J. Abou Jaoude (11485932), David J. Kedziora (10573094), Clemens Benedikt (230638), Azfar Hussain (11485935), Sarah Jarvis (4925683), Alena Skrahina (5504123), Dzmitry Klimuk (11485938), Henadz Hurevich (11485941), Feng Zhao (90241), Nicole Fraser-Hurt (2636833), Nejma Cheikh (4487677), Marelize Gorgens (316352), David J. Wilson (11485944), Romesh Abeysuriya (8824172), Rowan Martin-Hughes (4431142), Sherrie L. Kelly (3753985), Anna Roberts (8969096), Robyn M. Stuart (3754000), Tom Palmer (159714), Jasmina Panovska-Griffiths (637509), Cliff C. Kerr (11185804), David P. Wilson (9160266), Hassan Haghparast-Bidgoli (3141792), Jolene Skordis (6417764), Ibrahim Abubakar (217017)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, using program objectives, similar modelling tools, relatively high burden, related deaths occur, focused care models, effective priority setting, 50 %, respectively, spending across existing, resistant tb infections, support analytical capacity, new interventions could, differentiated general populations, optima tb framework, middle income country, improve health impact, programmatic cost functions, optima tb tool, optima tb, tb spending, income countries, health resources

Relation: https://figshare.com/articles/figure/Progress_toward_national_and_global_TB_targets_for_a_TB_mortality_and_b_new_TB_infections_in_the_15_64_age_group_under_2015_and_optimised_allocations_of_national_TB_spending_/16687875

الاتاحة: https://doi.org/10.1371/journal.pcbi.1009255.g006

المؤلفون: Lara Goscé (11485929), Gerard J. Abou Jaoude (11485932), David J. Kedziora (10573094), Clemens Benedikt (230638), Azfar Hussain (11485935), Sarah Jarvis (4925683), Alena Skrahina (5504123), Dzmitry Klimuk (11485938), Henadz Hurevich (11485941), Feng Zhao (90241), Nicole Fraser-Hurt (2636833), Nejma Cheikh (4487677), Marelize Gorgens (316352), David J. Wilson (11485944), Romesh Abeysuriya (8824172), Rowan Martin-Hughes (4431142), Sherrie L. Kelly (3753985), Anna Roberts (8969096), Robyn M. Stuart (3754000), Tom Palmer (159714), Jasmina Panovska-Griffiths (637509), Cliff C. Kerr (11185804), David P. Wilson (9160266), Hassan Haghparast-Bidgoli (3141792), Jolene Skordis (6417764), Ibrahim Abubakar (217017)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, using program objectives, similar modelling tools, relatively high burden, related deaths occur, focused care models, effective priority setting, 50 %, respectively, spending across existing, resistant tb infections, support analytical capacity, new interventions could, differentiated general populations, optima tb framework, middle income country, improve health impact, programmatic cost functions, optima tb tool, optima tb, tb spending, income countries, health resources

Relation: https://figshare.com/articles/dataset/Interventions_included_in_the_Belarus_analysis_/16687881

الاتاحة: https://doi.org/10.1371/journal.pcbi.1009255.t002

المؤلفون: Lara Goscé (11485929), Gerard J. Abou Jaoude (11485932), David J. Kedziora (10573094), Clemens Benedikt (230638), Azfar Hussain (11485935), Sarah Jarvis (4925683), Alena Skrahina (5504123), Dzmitry Klimuk (11485938), Henadz Hurevich (11485941), Feng Zhao (90241), Nicole Fraser-Hurt (2636833), Nejma Cheikh (4487677), Marelize Gorgens (316352), David J. Wilson (11485944), Romesh Abeysuriya (8824172), Rowan Martin-Hughes (4431142), Sherrie L. Kelly (3753985), Anna Roberts (8969096), Robyn M. Stuart (3754000), Tom Palmer (159714), Jasmina Panovska-Griffiths (637509), Cliff C. Kerr (11185804), David P. Wilson (9160266), Hassan Haghparast-Bidgoli (3141792), Jolene Skordis (6417764), Ibrahim Abubakar (217017)

مصطلحات موضوعية: Medicine, Biotechnology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Biological Sciences not elsewhere classified, Information Systems not elsewhere classified, using program objectives, similar modelling tools, relatively high burden, related deaths occur, focused care models, effective priority setting, 50 %, respectively, spending across existing, resistant tb infections, support analytical capacity, new interventions could, differentiated general populations, optima tb framework, middle income country, improve health impact, programmatic cost functions, optima tb tool, optima tb, tb spending, income countries, health resources

Relation: https://figshare.com/articles/dataset/Interventions_with_defined_constraints_in_the_optimisation_analysis_/16687884

الاتاحة: https://doi.org/10.1371/journal.pcbi.1009255.t003